Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 3 Undervalued Amgen Growth Opportunities to Watch
3 Undervalued Amgen Growth Opportunities to Watch
3 Undervalued Amgen Growth Opportunities to Watch
Submitted by
admin
on June 16, 2014 - 9:03pm
Source:
Motley Fool
News Tags:
Amgen
evolocumab
Kyprolis
brodalumab
AMG-334
Headline:
3 Undervalued Amgen Growth Opportunities to Watch
Do Not Allow Advertisers to Use My Personal information
